Third, with regard to the questionnaire, we discovered a highly significant reduction in symptoms measured by the SSS, FSS, and pain analogue scale, as well as a reduction in CSA, after 1, 3, and 6 months post-injection when we assessed patient status and compared the baseline evaluation with the results after the injection process.
← all excerpts
Predicting CTS Diagnosis and Prognosis Based on Machine Learning Techniques.
1
—
—